Zoloft During Pregnancy
The Food and Drug Administration has warned that women who use the antidepressant Zoloft during pregnancy are more likely than non-users to give birth to a child with heart defects or other serious birth defects. The FDA’s Zoloft warnings were echoed by the results of multiple studies published in the New England Journal of Medicine (NEJM), which also found an increased birth defects risk from using Zoloft while pregnant.
According to an FDA warning, mothers who use Zoloft during the third trimester of pregnancy are six times more likely than non-users to give birth to a child with persistent pulmonary hypertension of the newborn (PPHN). These findings were based on the results of a NEJM study comparing the birth defects risk of Zoloft with that of other antidepressants.
Another study publish by the NEJM found that women who used Zoloft or a similar class of antidepressants during the first trimester of pregnancy were more than twice as likely than non-antidepressant users to give birth to a child with serious birth defects. Women who used Zoloft or other drugs in its class early in their pregnancy were more likely to deliver a child with heart defects such as ventricular outflow tract obstruction defects, hypoplastic left heart syndrome, septal defects and other heart defects.
The FDA has advised women who are taking Zoloft and who wish to become pregnant to talk with their doctors about when it would be safe to conceive. Because there are risks both from taking Zoloft during the first trimester and from stopping treatment, only a doctor can advise women about whether it is safe to stop taking Zoloft.
If you or a loved one used Zoloft or other antidepressants while pregnant and gave birth to a child with heart defects or other birth defects, you may qualify to file a lawsuit. For a free legal consultation, contact the lawyers at Hissey Kientz, LLP by calling toll-free at 1-866-275-4454, or by filling out the free case evaluation form located on this page.